Description

DSIP – 5 mg

(Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first identified in the hypothalamus and characterized by its potential to modulate sleep patterns, stress response, and neuroendocrine regulation. The synthetic form of DSIP has been studied in experimental models for its influence on the central nervous system, its adaptogenic properties, and its potential role in maintaining homeostasis under physiological stress.

Research has explored DSIP for its neuroprotective, antioxidant, and sleep-modulating effects, as well as for its potential to support pituitary hormone balance and cellular recovery mechanisms.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• Neuroendocrine modulation: Interacts with hypothalamic and pituitary pathways influencing hormonal balance, particularly ACTH, LH, and GH secretion.

• Sleep regulation: Promotes natural sleep cycles and normalization of circadian rhythms in experimental subjects.

• Neuroprotective effects: Demonstrates antioxidant and anti-stress activity within central nervous system models.

• Mitochondrial support: May stabilize cellular energy processes and protect against oxidative stress.

• Corticosteroid modulation: Studied for reducing stress-induced elevations in cortisol levels.

---

Potential Benefits (Based on Preclinical Research):

• Normalization of sleep architecture and circadian rhythm

• Reduction of stress-related responses in neurological models

• Potential enhancement of recovery and cellular resilience

• Support for neuroprotection and hormonal balance

• Investigated for applications in fatigue, adaptation, and stress physiology research

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.